362 related articles for article (PubMed ID: 32593043)
1. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
[TBL] [Abstract][Full Text] [Related]
2. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
3. Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
Clin Neurol Neurosurg; 2020 Aug; 195():105951. PubMed ID: 32492588
[TBL] [Abstract][Full Text] [Related]
4. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease.
Moccia M; Pappatà S; Picillo M; Erro R; Coda AR; Longo K; Vitale C; Amboni M; Brunetti A; Capo G; Salvatore M; Barone P; Pellecchia MT
J Neurol; 2014 Nov; 261(11):2112-8. PubMed ID: 25119838
[TBL] [Abstract][Full Text] [Related]
6. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.
Kaasinen V; Kinos M; Joutsa J; Seppänen M; Noponen T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1931-7. PubMed ID: 24867256
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
8. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
[TBL] [Abstract][Full Text] [Related]
9. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N
Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
[TBL] [Abstract][Full Text] [Related]
11. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
[TBL] [Abstract][Full Text] [Related]
12. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
[TBL] [Abstract][Full Text] [Related]
13. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
14. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.
Yang Z; Xie Y; Dou K; Yang L; Xie A
Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
Benamer HT; Patterson J; Wyper DJ; Hadley DM; Macphee GJ; Grosset DG
Mov Disord; 2000 Jul; 15(4):692-8. PubMed ID: 10928580
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.
Di Giuda D; Camardese G; Bentivoglio AR; Cocciolillo F; Guidubaldi A; Pucci L; Bruno I; Janiri L; Giordano A; Fasano A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1937-48. PubMed ID: 22976499
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort.
Kim R; Lee J; Kim Y; Kim A; Jang M; Kim HJ; Jeon B; Kang UJ; Fahn S
Parkinsonism Relat Disord; 2018 Jun; 51():49-54. PubMed ID: 29523394
[TBL] [Abstract][Full Text] [Related]
18. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
19. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
[TBL] [Abstract][Full Text] [Related]
20. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
